85259-33-2 Usage
General Description
Methyl 2-bromo-2-(4-nitrophenyl)acetate is a chemical compound with the molecular formula C9H8BrNO4. It is an organic compound that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. methyl 2-bromo-2-(4-nitrophenyl)acetate contains a bromine atom and a nitro group, making it a versatile building block for the production of various organic molecules. It can be used in the synthesis of diverse products such as anti-inflammatory drugs, fungicides, and insecticides. Methyl 2-bromo-2-(4-nitrophenyl)acetate is a valuable chemical compound in the field of organic synthesis due to its ability to introduce functional groups into complex molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 85259-33-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,2,5 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 85259-33:
(7*8)+(6*5)+(5*2)+(4*5)+(3*9)+(2*3)+(1*3)=152
152 % 10 = 2
So 85259-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrNO4/c1-15-9(12)8(10)6-2-4-7(5-3-6)11(13)14/h2-5,8H,1H3
85259-33-2Relevant articles and documents
NAMPT MODULATORS
-
Paragraph 0305, (2021/08/13)
Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
BTK INHIBITOR
-
Paragraph 0362-0363, (2017/11/16)
Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 00794; 00795, (2015/09/28)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
